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Background. We aimed to estimate the prevalence of and explore risk factors for Mycobacterium tuberculosis infection among 
adolescents in a high tuberculosis (TB) and human immunodeficiency virus (HIV) prevalence setting.
Methods. A cross-sectional study of adolescents (10–19 years) randomly selected from a demographic surveillance area (DSA) 
in rural KwaZulu-Natal, South Africa. We determined M tuberculosis infection status using the QuantiFERON-TB Gold-plus assay. 
We used HIV data from the DSA to estimate community-level adult HIV prevalence and random-effects logistic regression to iden-
tify risk factors for TB infection.
Results. We enrolled 1094 adolescents (548 [50.1%] female); M tuberculosis infection prevalence (weighted for nonresponse by age, sex, 
and urban/rural residence) was 23.0% (95% confidence interval [CI], 20.6–25.6%). Mycobacterium tuberculosis infection was associated 
with older age (adjusted odds ratio [aOR], 1.37; 95% CI, 1.10–1.71, for increasing age-group [12–14, 15–17, and 18–19 vs 10–11 years]), 
ever (vs never) having a household TB contact (aOR, 2.13; 95% CI, 1.25–3.64), and increasing community-level HIV prevalence (aOR, 
1.43 and 95% CI, 1.07–1.92, for increasing HIV prevalence category [25%–34.9%, 35%–44.9%, ≥45% vs <25%]).
Conclusions. Our data support prioritizing TB prevention and care activities in TB-affected households and high HIV preva-
lence communities.
Keywords.  IGRA; latent Mycobacterium tuberculosis infection; risk factors.
As an airborne infection, the risk of Mycobacterium tuber-
culosis infection is determined, in part, by the risk of contact 
with individuals with infectious tuberculosis (TB) disease 
[1]. Mycobacterium tuberculosis infection in young children 
(<10  years) is used as a marker of recent transmission and 
to make inferences about transmission in the population [2, 
3]. Compared to older children and adults, young children 
have limited social contacts and are more likely than older 
children and adults to be infected within the household [4–7]. 
However, empirical evidence from both epidemiologic and mo-
lecular studies in high TB prevalence settings has shown that 
household transmission accounts for only between 8% and 20% 
of all transmission [8–12].
Throughout adolescence, young people have increasing so-
cial contact with the wider community and thus increased 
risk of M tuberculosis exposure and infection [7, 13, 14]. This 
suggests that M tuberculosis infection in adolescents might be 
a more representative measure of community-wide transmis-
sion than M tuberculosis infection in young children (aged 
<10  years), but there are few population-based studies from 
sub-Saharan Africa. We aimed to determine the prevalence of 
and risk factors for M tuberculosis infection among adolescents 




The study was conducted in the southern part of the Africa 
Health Research Institute’s demographic surveillance area 
(DSA), in uMkhanyakude district, KwaZulu-Natal, South 
Africa, which has a resident population of approximately 60 000 
and an adult HIV prevalence estimated at 36.6% in 2016 [15]. 
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The annual notification rate of all TB cases in KwaZulu-Natal 
was 394 per 100 000 population in 2018 (Oral personal commu-
nication, March 2020).
Study Participants and Procedures
We randomly selected adolescents (aged 10–19  years) from 
the complete sampling frame of all residents (individuals re-
ported as intending to spend the majority of nights at a house-
hold within the DSA). Between November 2017 and December 
2018, the selected individuals were visited at home and invited 
to take part. Because this study was originally designed to esti-
mate M tuberculosis incidence at 12 months among adolescents 
who were negative at baseline, adolescents reporting any his-
tory of treatment for active TB were excluded. A standard ques-
tionnaire was administered that included questions on Bacillus 
Calmette-Guérin (BCG) vaccination, history of lifetime house-
hold TB contact, admission to hospital, smoking (and passive 
smoking), alcohol intake, and history of HIV testing. All par-
ticipants were examined for presence of BCG scars (documen-
tation of immunizations was also checked) and were asked 
history of attendance (including frequency of attendance in the 
previous month; duration, and number of people present at the 
last visit) at relevant indoor gathering places (school, church, 
health facility, and public transport). Data were collected on 
electronic tablets using the REDCap application (Vanderbilt 
University, Nashville, TN) [16].
Participants who were not known to be HIV positive, or 
whose most recent negative HIV test was more than 3 months 
previously, were encouraged to check their HIV status via a 
rapid HIV test on a fingerpick blood sample. Those who de-
clined rapid testing were offered the option of undergoing an-
onymized laboratory enzyme-linked immunosorbent assay 
(ELISA) for research purposes only (further details on HIV 
testing are presented in the Supplementary Material Section 1). 
Participants newly testing HIV positive, and those previously 
diagnosed with HIV but not on antiretroviral therapy (ART), 
were referred to initiate ART [17]. Participants with TB symp-
toms (any of cough [≥2 weeks, or any duration if HIV positive], 
fever, night sweats, or weight loss) were asked to submit sputum 
for Xpert MTB/RIF testing. Those unable to produce sputum 
were referred to their nearest clinic for further management in 
accordance with national guidelines [18].
Information extracted from the DSA database included pre-
vious HIV test results (for those aged ≥15  years) and house-
hold data including urban/rural location, number of residents, 
socioeconomic status (SES), and distance to the nearest clinic. 
Community HIV prevalence (for individuals ≥15  years) was 
calculated using 2017 surveillance data by means of a 2-dimen-
sional Gaussian kernel density of 3-km search radius, based on 
previously described methods [19]. Thus, the HIV prevalence 
for each household was estimated based on the population and 
number of known HIV-positive individuals within this search 
radius superimposed across the household. The HIV prevalence 
estimates for each household were categorized into 4 groups 
based on the frequency distribution of HIV prevalence of all 
households in the study area. The lowest category was coded “1” 
and included households with HIV prevalence below 25%. The 
highest category was coded “4” and included households with 
HIV prevalence at least 45%.
Laboratory Procedures
Details of laboratory testing are provided in the Supplementary 
Material Section 1. Briefly, venous blood was tested for M tuber-
culosis infection using the QuantiFERON-TB Gold Plus (QFT-
Plus) assay (QIAGEN, Hilden, Germany) according to the 
manufacturer’s instructions [20]. Sputum samples were tested 
using Xpert MTB/RIF (Cepheid, Sunnyvale, CA) at Hlabisa 
district hospital laboratory.
Definitions
Mycobacterium tuberculosis infection was defined as interferon-
gamma (IFN-γ) concentration ≥0.35 IU/mL (calculated as 
either TB1 or TB2 antigen minus nil) per the manufacturer’s 
guideline [20]. Lifetime household TB contact was defined 
as either having lived in the same household as a person with 
TB disease for ≥2 weeks or having cared for a person with 
TB during the participant’s lifetime based on information re-
ported by the participant and the parent for participants aged 
10–17 years. Detailed definitions for exposures are provided in 
the Supplementary Material Section 2.
Statistical Analysis
A sample size of 1100 was sufficient to estimate the prevalence 
of M tuberculosis infection of 50% with a precision of ±3% at 
5% significance level. To account for nonparticipation (both in-
ability to contact participants and refusal to participate), a total 
1998 adolescents were selected.
To account for nonparticipation, the weighted M tuber-
culosis infection prevalence was calculated by multiplying 
the crude prevalence by the inverse of probability of par-
ticipation in strata-defined age, sex, and urban/rural resi-
dence. Characteristics of individuals included in the analysis 
were compared with those who were selected but were not 
included (because of nonparticipation or missing results) 
using χ 2 tests. Random-effects logistic regression taking ac-
count of clustering within households was used to estimate 
odds ratios (ORs) and 95% confidence intervals (CIs) for the 
association of M tuberculosis infection with potential risk 
factors. To account for the interrelationships between the po-
tential risk factors, a hierarchical approach [21] with 3 levels 
(community, household, and individual) was used to build 
a multivariable model (Figure  1). First, community factors 
associated with the outcome at P < .20 on univariable anal-






/ofid/article/8/1/ofaa520/5974127 by guest on 10 M
ay 2021
M tuberculosis Infection, South Africa • ofid • 3
were added sequentially to the core model and retained if 
they remained associated with the outcome at P <  .20 after 
adjusting for community factors and SES. Associations with 
individual-level factors were determined similarly, with age 
included in all the models as an a priori confounder. A com-
plete case analysis was performed. Analyses were performed 
using Stata version 14.2 (College Station, TX).
Patient Consent Statement
The study was approved by the London School of Hygiene 
& Tropical Medicine Ethics Committee (ref. 10515), the 
Biomedical Research Ethics Committee of the University 
of KwaZulu-Natal (ref. BE483/15), and the KwaZulu-Natal 
Department of Health (ref. 184/16). Individual informed 
written consent was obtained from participants aged 
18–19 years and from parents/guardians of participants aged 
10–17 years, with informed assent from the participant. For 
participants or parent/guardians who could not read and/or 
write, a witness who was not a member of the research team 
attested to the informed consent procedure.
RESULTS
Participant Enrollment
Field workers successfully visited the homes of 1809 of 1998 
(90.5%) selected individuals (Figure 2); 1173 of 1809 (64.8%) 
were screened for eligibility, 575 (31.8%) were not found, and 61 
(3.4%) refused participation. Among those screened, 35 (3.0%) 
had a history of previous or current TB treatment, 3 (0.2%) 
were ineligible after crosschecking their date of birth, and the 
remaining 1135 (96.8%) were enrolled. The QFT-plus results 
were available for 1094 participants (Figure 2).
Individuals included in the analysis compared with those not 
included were more likely to be from rural communities and 
from communities with lower HIV prevalence (Supplementary 
Table 1). There were no differences by age, sex, or SES.
Among 1094 participants, 548 (50.1%) were female, 266 
(24.4%) had a lifetime household TB contact, 379 (34.6%) were 
from urban communities, 965 (88.6%) had evidence of BCG 
vaccination, and 43 (3.9%) were HIV positive (Table  1). The 
median distance to the nearest clinic was 2.7 km (interquar-
tile range, 1.7–4.2). Overall, 898 participants had a known HIV 
status: 641 were through testing in the study, 103 through sur-
veillance activities, and 154 through self-reporting.
Mycobacterium tuberculosis Infection Prevalence
Two hundred forty-nine participants had IFN-γ values ≥0.35 
IU/mL, giving a crude M tuberculosis infection prevalence of 
22.8% (95% CI, 20.4%–25.3%). The M tuberculosis infection 
prevalence weighted for nonparticipation by age, sex, and rural/
urban residence was 23.0% (95% CI, 20.6%–25.6%). The dis-
tribution of IFN-γ values for all participants is presented in 
Supplementary Figure 1.
Distal Factors




- BCG vaccination status




- Current alcohol intake
- Education level at time of
survey
- History of  admission to
hospital
- Contact with adult males
- Contact with adult females
- Attendance at church
(previous month)
- Visits to other homesteads
during the day (previous
week)
- Sharing sleeping room with
other people at time of  survey







- Number of  current residents
- Reported smoker in current
household.
- Distance to clinic
A priori factors
- Age
- Household socioeconomic status
Mycobacterium
tuberculosis infection
Community Household Individual Outcome






/ofid/article/8/1/ofaa520/5974127 by guest on 10 M
ay 2021
4 • ofid • Mzembe et al
Risk Factors for Mycobacterium tuberculosis Infection
At community level, there was evidence of an association be-
tween M tuberculosis infection and community HIV prevalence 
(Table 2). The odds of M tuberculosis infection increased with 
increasing community HIV prevalence (linear OR: 1.43 for 
each unit increase in community HIV prevalence category).
At the individual level, M tuberculosis infection was pos-
itively associated with older age and having a lifetime house-
hold TB contact (Table 2). The odds of M tuberculosis infection 
increased with increasing age (linear OR: 1.37 for each unit 
increase in age group) and were 2.1 times higher among parti-
cipants with history of a household TB contact compared with 
those without. There was no evidence of association between 
M tuberculosis infection and BCG vaccination or HIV infec-
tion after adjusting for community, household, and individual-
level factors (Table  2). Mycobacterium tuberculosis infection 
was inversely associated with number of visits to church in the 
previous month and houses visited during day hours in the 
previous week. There was no evidence of an association with 
sharing a sleeping room with other people or with other esti-
mates of social contacts (Table 2).
DISCUSSION
In this high TB/HIV prevalence setting, the prevalence of M tu-
berculosis infection (23.0%) among adolescents was lower than 
found in the Western Cape province, South Africa [22, 23]. 
To our knowledge, this is the first study reporting strong evi-
dence of an association between M tuberculosis infection and 
increased community-level HIV prevalence.
Recent data on M tuberculosis infection among adolescents 
largely come from 2 studies in densely populated townships in 
Western Cape province where prevalence (defined as tuberculin 
skin test [TST] induration ≥10  mm) was much higher: 37% 
among 5- to 17-year-olds [23] and 42.2% (95% CI, 40.9–43.6) 
[22] among 12- to 18-year-olds. Possible explanations for this 
difference include differences in social contact patterns, because 
our study was conducted in a less densely populated rural area. 
A second explanation could be differences in population prev-
alence of active TB; at the time of the studies in Western Cape 
(2009), the annual TB notification was approximately 1400 per 
100  000 [22, 23] compared with 577 per 100  000 in 2015 for 
uMkhanyakude district (the setting of our study) [24]. A third 
possible explanation is differences in HIV prevalence among 
notified TB patients. For example, in 2015 the HIV prevalence 
among people notified with TB was 64.3% in uMkhanyakude 
district compared with 44.6% in Cape Town [24]. At individual 
level, HIV-positive individuals are likely to be less infectious 
due to reduced likelihood of cavitary lung disease [25].
A 2013 TST survey among school-going children aged 
6–8  years in our setting reported an M tuberculosis infection 
prevalence of 12.4% (95% CI, 10.2%–15.0%) using TST ≥10 mm 





Not assessed for enrolment: 636 (31.8%)
- 460 (73.2%) not at home
- 115 (18.1%) moved from location
- 61 (3.6%) refused participation
Not enrolled: 38 (1.9%)
- 35 (92.1%) previous/current TB treatment
- 3 (7.9%) not age eligiblle
Excluded fr om analysis: 41 (2.1%)
- 21 (51.2%) insucient blood sample
-14 (34.1%) declined blood sample collection
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and community-level HIV prevalence, but the odds of M tu-
berculosis infection were slightly higher (adjusted OR, 1.8; 95% 
CI, 1.1–3.1) in participants living in households with at least 2 
HIV-positive individuals. The higher M tuberculosis infection 
prevalence and the association with increased age in the current 
study (in older individuals) reflect longer cumulative exposure 
to people with infectious TB and increased social contact of 
older adolescents with the wider community [7, 14]. In addi-
tion, the older adolescents in our study would also have experi-
enced a higher risk of TB infection in their early lives, because 
TB notification rates in KwaZulu-Natal have fallen over the last 
decade [24].
Similar to the Western Cape study [22], we found increased 
odds of M tuberculosis infection among participants with a 
lifetime household TB contact. Thus, transmission within 
households of individuals with TB disease remains an impor-
tant consideration for TB prevention and care programs and 
highlights the need for enhancing household TB contact tracing 
to reduce transmission. Despite this, 68% of our participants 
with M tuberculosis infection reported to have never lived in the 
same house as an individual with TB disease.
The DSA setting of our study allowed us to investigate the 
effect of the participant’s community HIV prevalence on M 
tuberculosis infection. Although ART reduces the risk of TB 
disease after infection and ART access has improved over the 
years [27], HIV-positive individuals remain at elevated risk of 
TB disease [28, 29]. Through long-term, population-based sur-
veillance, we have shown that HIV prevalence has remained 
consistently high in certain communities within the DSA over 
several years [19, 27]. We have also shown that active TB, and 
specifically drug-resistant TB, are associated with those high 
HIV prevalence areas [30, 31]. The association between higher 
M tuberculosis infection prevalence among adolescents with 
higher community HIV prevalence suggests possible clustering 
and continued transmission in these communities. Targeted ef-
forts to find and treat TB in such communities could be effective 
in reducing M tuberculosis transmission. Our findings also sup-
port the need for research to explore the feasibility and impact 
of expanded TB preventive therapy in high transmission areas, 
in line with World Health Organization recommendations and 
the South African National Strategic Plan [17, 32].
The odds of M tuberculosis infection were lower among parti-
cipants who reported visiting at least 3 houses during day hours 
in the previous week and those who attended at least 3 prayer 
meetings in the previous month. This is likely due to residual 
confounding. In addition, a recent mathematical modeling sug-
gested that although household and repeated nonhousehold 
contacts contribute approximately 50% of contact time, they, 
respectively, contribute to only approximately 13% and 8% of 
disease transmission, and that approximately 79% of transmis-
sion is likely to be from nonrepeated (ie, “casual”) contacts [33]. 
Thus, the apparent protective effect seen in our data from at-
tendance to prayer meetings and visits to other houses could 
be because the contacts during these visits are likely to be 
repetitive.
This study has limitations. First, participants from urban 
communities and communities with high HIV prevalence were 
underrepresented. Because M tuberculosis infection prevalence 
was higher in communities with HIV prevalence ≥45%, our 
overall estimate for M tuberculosis infection prevalence may 
have been slightly underestimated. The estimate for M tubercu-
losis infection prevalence may have also been underestimated, 
because individuals with a history of current or previous TB 
treatment were excluded. However, this would only give a minor 
change in the estimate (as shown in Supplementary Section 
4). Another limitation is that social contact information was 
Table 1. Characteristics of Study Participants (n = 1094)
Characteristic N (%)
Sex  
 Female 548 (50.1)
 Male 546 (49.9)
Age (years)  
 10–11 237 (21.7)
 12–14 349 (31.9)
 15–17 297 (27.2)
 ≥18 211 (19.3)
Lifetime Household TB Contact (N = 1089)  
 No 823 (75.6)
 Yes 266 (24.4)
HIV Status  
 Negative 855 (78.2)
 Positive  43 (3.9)
 Unknown 196 (17.9)
BCG Vaccination (N = 1085)  
 Vaccinated 984 (90.7)
 Not vaccinated 101 (9.3)
Location  
 Rural 715 (65.4)
 Urban 379 (34.6)
Household Socioeconomic Index Tertilesa (1048)  
 Low 305 (29.1)
 Middle 350 (33.4)
 High 393 (37.5)
Number of Household Residents (N = 1070)  
 <6 333 (31.1)
 6–7 252 (23.6)
 8–10 248 (23.2)
 >10 237 (22.2)
Church Attendance in Previous 4 Weeks (N = 1073)  
 None 664 (61.9)
 1–2 times 176 (16.4)
 ≥3 times 233 (21.7)
Abbreviations: BCG, Bacillus Calmette-Guérin; HIV, human immunodeficiency virus; TB, 
tuberculosis.
aIndex scores obtained from a principal component analysis (as described in Supplementary 
Section 2) were categorized into worth tertiles with the lowest tertile coded “1” and la-
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Table 2. Risk Factors for Mycobacterium tuberculosis Infection Showing Odds Ratios Obtained From the Crude, Partial, and Fully Adjusted Models at 
Each Level of Hierarchical Approach
Variable QFT Positive n/N (%)
Crude OR  
(95% CI) P Value
 Adjusted ORa  
(95% CI) P Value




Community Level Factors        
Community HIV Prevalence (%)        
 <25% 12/85 (14.1)       
 25%–34.9% 133/618 (21.5)       
 35%–44.9% 61/261 (23.4) 1.43 (1.07–1.92) .02c     
 ≥45% 26/82 (31.7)       
Location        
 Rural 156/715 (21.8) 1 .34 1d .54   
 Urban 93/379 (24.5) 1.21 (0.81–1.80)  0.84 (0.48–1.47)    
Household Level Factors        
Distance to Nearest Clinic (km) (Quartiles)        
 <1.85 84/301 (27.9) 1 .13 1d .21 1e .30
 1.85–3.41 80/403 (19.9) 0.56 (0.34–0.92)  0.59 (0.35–1.01)  0.64 (0.36–1.14)  
 3.42–5.36 55/259 (21.2) 0.64 (0.38–1.08)  0.78 (0.43–1.42)  0.82 (0.43–1.59)  
 >5.36 30/131 (22.9) 0.71 (0.37–1.37)  1.02 (0.50–2.06)  1.21 (0.56–2.65)  
Household Social Economic Index Score 
(Tertiles)
       
 Low 74/305 (24.3) 1 .72 1d .75 1e .75
 Middle 79/350 (22.6) 0.87 (0.5–1.47)  0.81 (0.46–1.41)  0.81 (0.46–1.41)  
 High 83/393 (21.1) 0.81 (0.49–1.36)  0.89 (0.52–1.54)  0.89 (0.52–1.54)  
Number of Residents        
 <6 87/333 (26.1) 1 .25 1d .32 1e .41
 6–7 58/252 (23.0) 0.83 (0.49–1.41)  0.83 (0.47–1.45)  0.89 (0.48–1.65)  
 8–10 50/248 (20.2) 0.62 (0.35–1.09)  0.61 (0.34–1.11)  0.61 (0.32–1.18)  
 >10 46/237 (19.4) 0.60 (0.34–1.07)  0.64 (0.35–1.14)  0.65 (0.34–1.24)  
Reported Smoker in Household        
 No 197/880 (22.4) 1 .96 1d .53 1e .58
 Yes 47/207 (22.7) 0.99 (0.62–1.59)  0.85 (0.50–1.43)  0.85 (0.49–1.50)  
Individual-Level Factors        
Sex        
 Female 123/548 (22.4) 1 .85 1f .96 1g .80
 Male 126/546 (23.1) 1.04 (0.72–1.50)  0.99 (0.64–1.52)  0.95 (0.62–1.45)  
Age (Years)        
 10–11 49/237 (20.7)       
 12–14 62/349 (17.8)       
 15–17 71/297 (23.9) 1.32 (1.09–1.59) <.01c 1.36 (1.09–1.71)f,c .01 1.37 (1.10–1.71)g,c .01
 ≥18 67/211 (31.8)       
Lifetime Household TB Contact        
 No 168/823 (20.4) 1 .01 1f .02 1g .01
 Yes 78/266 (29.3) 1.90 (1.20–3.01)  1.90 (1.12–3.12)  2.13 (1.25–3.64)  
HIV Status        
 Negative 193/855 (22.6) 1 .88 1f .39 1g .35
 Positive 9/43 (20.9) 0.91 (0.34–2.40)  0.65 (0.20–2.11)  0.65 (0.20–2.09)  
 Unknown 47/196 (24.0) 1.11 (0.69–1.81)  1.41 (0.78–2.53)  1.43 (0.80–2.56)  
BCG Vaccination        
 Vaccinated 216/984 (22.0) 1 .24 1f .99 1g .65
 Not vaccinated 28/101 (27.7) 1.43 (0.78–2.65)  1.00 (0.47–2.15)  1.19 (0.32–2.98)  
Smoking        
 No 240/1070 (22.4) 1 .32 1f .81 1g .54
 Yes 6/18 (33.3) 1.98 (0.52–7.54)  0.82 (0.17–4.07)  0.61 (0.12–2.26)  
Alcohol Intake        
 No 226/1021 (22.1) 1 .21 1f .76 1g .75
 Yes 16/54 (29.6) 1.59 (0.72–3.54)  1.17 (0.44–3.06)  1.17 (0.45–3.04))  
Admission to Hospital        
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captured retrospectively by asking participants about their at-
tendance at indoor gathering places and details of the last visit. 
Although knowledge of attending an indoor gathering place 
would still be in memory, reporting errors might have been 
introduced concerning the frequency and duration of visits and 
numbers of people present, resulting in misclassification that 
may have obscured associations.
The strength of this study is that we had a large sample size 
that allowed us to estimate the prevalence with a high preci-
sion and gaveus the ability to detect important associations with 
potential risk factors. We believe that our estimate is reflective 
of M tuberculosis infection prevalence among adolescents in 
this setting. Moreover, the QFT-plus test was used, which is 
a more specific test for M tuberculosis infection than the TST. 
Furthermore, we experienced a very low proportion of indeter-
minate results. Another strength is that this study was nested 
within in a well defined DSA, which provided a comprehensive 
sampling frame and allowed us to determine the effect of 
nonparticipation on the estimate for prevalence.
CONCLUSIONS
In this high TB and HIV burden setting, the prevalence of M tu-
berculosis infection among adolescents was lower than reported 
from the Western Cape in South Africa. Community-level HIV 
prevalence, age, and lifetime household TB contact were associ-
ated with increased odds of M tuberculosis infection. Enhancing 
TB household contact tracing and targeted active case finding 
in high HIV prevalence communities has potential to reduce 
the burden of TB in this setting.
Supplementary Data
Supplementary materials are available at Open Forum Infectious Diseases 
online. Consisting of data provided by the authors to benefit the reader, 
the posted materials are not copyedited and are the sole responsibility 
Variable QFT Positive n/N (%)
Crude OR  
(95% CI) P Value
 Adjusted ORa  
(95% CI) P Value




 Yes 25/121 (20.7) 0.87 (0.48–1.60)  0.74 (0.37–1.48)  0.68 (0.34–1.36)  
Social Contact Factors        
Contact Hours With Adult Men        
 <100 63/274 (23.0) 1 .95 1f .76 1g .69
 100–1047 63/275 (22.9) 0.99 (0.58–1.67)  1.30 (0.70–2.43)  1.47 (0.78–2.76)  
 1048–2400 59/272 (21.7) 0.89 (0.53–1.52)  1.00 (0.53–1.87)  1.16 (0.62–2.18)  
 >2400 64/273 (23.4) 1.04 (0.62–1.76)  1.24 (0.66–2.32)  1.24 (0.66–2.31)  
Contact Hours With Adult Females        
 <160 68/277 (24.5) 1 .47 1f .83 1g .89
 160–1216 53/274 (19.3) 0.69 (0.41–1.18)  0.80 (0.43–1.49)  0.91 (0.49–1.66)  
 1216–2880 66/270 (24.4) 1.03 (0.61–1.74)  1.07 (0.57–2.00)  1.16 (0.63–2.16)  
 >2880 62/273 (22.7) 0.89 (0.53–1.50)  0.99 (0.53–1.84)  1.09 (0.59–2.00)  
Church Attendance in Previous Month        
 None 165/664 (24.8) 1 .08 1f .13 1g .04
 1–2 times 37/176 (21.0) 0.75 (0.44–1.26)  0.66 (0.35–1.23)  0.59 (0.32–1.10)  
 ≥3 times 41/233 (17.6) 0.58 (0.35–0.95)  0.58 (0.33–1.03)  0.49 (0.27–0.89)  
Health Facility Attendance (12 Months)        
 No 142/667 (21.3) 1 .26 1f .88 1g .83
 Yes 104/422 (24.6) 1.24 (0.85–1.81)  1.03 (0.66–1.61)  1.04 (0.68–1.62)  
Visiting Other Houses During the Day        
 None 169/720 (23.5) 1 .02 1f .02 1g .01
 1–2 houses 59/227 (26.0) 1.20 (0.76–1.88)  1.17 (0.69–1.91)  1.00 (0.60–1.69)  
 ≥3 houses 17/136 (12.5) 0.38 (0.19–0.78)  0.31 (0.13–0.72)  0.28 (0.12–0.66)  
Sharing Sleeping Room With Other People        
 None 84/363 (23.1) 1 .88 1f .71 1g .56
 1 person 78/336 (23.2) 0.97 (0.61–1.54)  1.24 (0.73–2.11)  1.33 (0.78–2.26)  
 ≥2 persons 84/389 (21.6) 0.89 (0.57–1.40)  1.08 (0.64–1.83)  1.13 (0.66–1.93)  
Abbreviations: BCG, Bacillus Calmette-Guérin; CI, confidence interval; HIV, human immunodeficiency virus; OR, odds ratio; QFT, QuantiFERON TB-Gold plus; TB, tuberculosis.
aPartially adjusted by a priori confounders and variables remaining significant (P < .2) at higher levels in the hierarchy.
bAdjusted by a priori confounders, variables remaining significant (P < .2) at higher levels in the hierarchy, and variables remaining significant (P < .2) that levels in the hierarchy.
cOdds ratios modeled as a linear trend across the categories; n and % of QFT positive in each category shown for information only.
dAdjusted by community HIV prevalence.
eAdjusted by community HIV prevalence and socioeconomic status (a priori confounder at household level).
fAdjusted by community HIV prevalence, socioeconomic status, and age (a priori confounder at individual level).
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of the authors, so questions or comments should be addressed to the 
corresponding author.
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